The opioid epidemic is the most important and most serious public health crisis today. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from Huge Alerts.
A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm! The opioid epidemic is the most important and most serious public health crisis today. The effects are reported in overdose deaths but are also starkly evident in declines in sense of well-being and general health.As per most recent research, JEC analysis has found that the opioid epidemic has cost the U.S. nearly $1.5 trillion in 2020, and this figure is likely increasing each year! As the Opioid crisis continues to claim lives, Scilex Holding Company (NASDAQ: SCLX) is addressing the problem with promising solutions and already has 3 FDA approved offerings under its belt! SCLX is focused on developing non-opioid pain management products and is filling a much-needed area of the health care sector, that of developing non-opioid pain relief products. SCLX already has THREE commercialized products that are already FDA APPOVED and three are in development and could be inching towards FDA approval too! A few other big reasons to have your eyes on this rising healthcare firm include a $5.50 price target from Zacks SCR and a HEAVY short interest of 12.71M shares (As of 11/1/24). There could be an imminent short squeeze ahead for this small cap NASDAQ company! See how SCLX is offering viable solutions to a growing healthcare crisis while building shareholder value at the same time! Regards, Huge Alerts |
| Our mailing address is:
Behind the Markets, LLC
4260 NW 1st Avenue, Suite 55
Boca Raton, FL 33431 We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of Scilex Holding Company (NASDAQ: SCLX). The compensation consists of a fixed fee of $2,500 and was received/will be received from Sideways Frequency. This compensation should not be considered as an endorsement of the securities of adviser Scilex Holding Company (NASDAQ: SCLX) and we are not responsible for any errors or omissions in any information provided about the securities of Scilex Holding Company (NASDAQ: SCLX) by Huge Alerts and Sideways Frequency. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 11/05/24. Behind the Markets
Copyright © 2024 Behind the Markets, LLC, All rights reserved.
You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices.
Unsubscribeinvisiblelink
Today's Bonus Content: Top 5 Stocks for a Trump Win in 2024 (By clicking this link you agree to receive emails from Trading Tips and our affiliates. You can opt out at any time)
|
|
